Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.7 USD | +7.25% | +7.56% | +117.65% |
Financials (USD)
Sales 2024 * | 148M | Sales 2025 * | 178M | Capitalization | 557M |
---|---|---|---|---|---|
Net income 2024 * | -14M | Net income 2025 * | 1M | EV / Sales 2024 * | 3.77 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.13 x |
P/E ratio 2024 * |
-41.1
x | P/E ratio 2025 * |
555
x | Employees | 126 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.31% |
Latest transcript on Heron Therapeutics, Inc.
1 day | +7.25% | ||
1 week | +7.56% | ||
1 month | +59.48% | ||
3 months | +39.10% | ||
6 months | +200.81% | ||
Current year | +117.65% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 23-02-20 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 23-06-15 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 18-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 23-02-20 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 21-09-19 |
Craig Johnson
BRD | Director/Board Member | 62 | 14-01-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 3.7 | +7.25% | 2,664,356 |
24-05-30 | 3.45 | +5.50% | 2,537,128 |
24-05-29 | 3.27 | -4.11% | 2,790,315 |
24-05-28 | 3.41 | -0.87% | 1,928,985 |
24-05-24 | 3.44 | -0.86% | 1,108,091 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+117.65% | 557M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- HRTX Stock